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Portal vein thrombosis after sleeve gastrectomy  
in 32-year-old morbidly obese woman
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 Abstract
Portal vein thrombosis after laparoscopic procedures is an uncommon complication, but potentially life 
threating. Possible etiologic factors include venous stasis due to increased intra-abdominal pressure, in-
traoperative manipulation, or damage to the splanchnic endothelium and systemic thrombophilia states. 
We describe a case of a 32 year old morbidly obese patient, qualified for surgical treatment of obesity. 
After a laparoscopic gastric resection — a sleeve gastrectomy — on the 20th day after hospital discharge, 
the patient was re-admitted to the surgical ward due to uncharacteristic abdominal pain, nausea, vomiting 
and increased cholestasis indicators. The patient was diagnosed with portal system thrombosis. Follo-
wing the treatment the patient achieved complete remission of symptoms. Given a growing number of 
laparoscopic procedures, we may expect an increasing number of similar complications. This condition 
needs to be considered in patients with unexplained abdominal pain after several laparoscopic procedures. 
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 Streszczenie
Zakrzepica żyły wrotnej po zabiegach laparoskopowych jest rzadkim powikłaniem, ale potencjalnie zagraża-
jącym życiu. Do rozwoju zakrzepicy predysponują liczne czynniki, jak zastój żylny z powodu zwiększonego 
ciśnienia w jamie brzusznej, śródoperacyjna manipulacja wewnątrzotrzewnowa, uszkodzenie śródbłonka 
naczyń trzewnych oraz trombofilią. 
Opisujemy przypadek 32-letniej pacjentki z  patologiczną otyłością zakwalifikowaną do chirurgicznego 
leczenia otyłości. Po laparoskopowej resekcji rękawowej żołądka, w 20. dniu po wypisie ze szpitala, 
pacjentka została ponownie przyjęta na oddział chirurgiczny ze względu na nietypowe bóle brzucha, nud-
ności, wymioty i podwyższenie wskaźników cholestazy. U pacjentki stwierdzono zakrzepicę żyły wrotnej. 
Po wdrożeniu leczenia zachowawczego uzyskano całkowitą remisję objawów. Biorąc pod uwagę rosnącą 
liczbę zabiegów laparoskopowych, należy spodziewać się zwiększenia częstości występowania podobnych 
powikłań. Powinno się o tym zawsze pamiętać u pacjentów z niewyjaśnionymi bólami brzucha poddanych 
procedurom laparoskopowym. 
Słowa kluczowe: otyłość, resekcja rękawowa żołądka, laparoskopia, zakrzepica żyły wrotnej, ból brzucha
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Introduction
Portal vein thrombosis is a  rare, but potentially, 
life threatening condition. Its diagnosis often creates 
considerable diagnostic challenges because of limited 
specific symptoms. The predisposing factors for devel-
oping portal vein thrombosis are the formation of clots 
in the vessels, consequently leading to the impairment 
of their patency. We divide them into two main groups, 
known as systemic and local factors. Among systemic 
factors the following factors can be suggested: coagula-
tion disorders, proliferative processes and multifactorial 
thrombophilia, advanced age, obesity, pregnancy and the 
postpartum period, oral hormonal contraceptives and cig-
arette smoking. The second group comprises local factors 
of which the most important is cirrhosis (responsible for 
nearly 40% of cases of portal vein thrombosis) as well 
as trauma, infection, local inflammation, and proliferative 
processes in the surrounding organs [1, 2].
Clinical situations, which may predispose to portal 
vein thrombosis can also be related to the method of 
surgery performance, especially in the coexistence of 
other thrombosis risk factors [1, 3–5]. Taking into account 
the current knowledge, in the patients undergoing lap-
aroscopic surgery the exact cause of this complication 
after laparoscopy is not fully clear. On the other hand, in 
laparoscopy surgery cases, there is a group of factors 
that may predispose to it: among the others an induction 
of pneumoperitoneum insufflation should be mentioned. 
The increase in the intra-abdominal pressure may result 
in a decrease in the flow in the portal vein, which cre-
ates favorable conditions for the thrombus formation. 
Additionally, it has been proven that the intraoperative 
manipulation around blood vessels may predispose to 
the thrombosis occurrence [6]. Another important pre-
disposing factor is failed prophylaxis in the form of low 
molecular weight heparin administration. It is worth not-
ing that despite over 20 years of experience in minimally 
invasive techniques, we have yet to find papers on portal 
vein thrombosis in procedures other than those in which 
there is a direct breach of the portal area along with its 
tributaries and branching [1, 3, 7].
Case report
The case report concerns a  32-year-old morbidly 
obese patient (BMI = 45 kg/m2), with no other comor-
bidities, who smoked about 20 cigarettes a day before 
a bariatric procedure and applying hormonal oral con-
traception until the last cycle before the surgery. After 
numerous tests, which included gastroscopy, a  chest 
X-ray, an echocardiogram, a venous Doppler ultrasound 
of the lower limbs and abdomen, an ECG, an ultrasound 
of the thyroid as well as lab tests, she was cleared for 
laparoscopic surgery — a sleeve gastrectomy. The sur-
gery was performed under general anesthesia. The an-
tithrombotic prophylaxis and a three-day perioperative 
antibiotic therapy were administered. After the pneumo-
peritoneum was produced, the trocars were introduced 
in typical locations, and the patient was put in a Trende-
lenburg position, the peritoneal cavity was inspected and 
it showed signs of fatty liver. A sleeve gastrectomy was 
performed using a linear endostapler. The control of the 
anastomotic leak (methylene blue) went negatively. After 
checking hemostasis, the draining of the operated area 
was conducted. No complications were experienced in 
the course of peri- and postoperative procedures. Af-
ter a radiological anastomotic leak trial, the patient was 
discharged on postoperative day three, in good general 
condition, without pain, with a recommendation to use 
low molecular weight heparin for another 10 days. On 
the 20th day after the surgery, the patient came back to 
the hospital with abdominal pain lasting for three days, 
radiating to the back, with nausea and vomiting. The prob-
lems intensified the day she came back to the hospital. In 
addition, the patient reported a periodic low-grade fever 
and general weakness. During hospital admission the 
patient denied any dietary mistakes. The physical exam-
ination during admission indicated a slightly distended 
belly, mainly in center epigastric and on the right, without 
any peritoneal signs. The peristalsis was present, lazy. 
A discrete yellowing of the white parts of the eyes was de-
tected. In laboratory studies: CRP 294 mg/L, Hg 11.5 g/dL, 
RBC 4.680 million/mm3, WBC 11 thousand/ mm3, PLT 60 
thousand/mm3, prothrombin content of 78%, 18 s pro-
thrombin time, INR 1.31, ALAT 67U/L, AST 58 U/L, total 
bilirubin 2.35 mg/dL, in urine diastase 1637 U/L, serum 
alkaline phosphatase 201 U/L, total protein was 53 mg/dL. 
The abdominal ultrasound revealed no abnormalities. 
The plain abdominal X-ray detected single fluid levels, 
without any evidence of obstruction. The patient was 
hospitalized and given a  conservative treatment. The 
patient did not achieve a clinical improvement and the 
markers of cholestasis (bilirubin total 4.66 mg/dL, alkaline 
phosphatase 240 U/L) were on the rise. On the 3rd day of 
hospitalization a cholangio-MR was performed. It showed 
inflammation of the gallbladder and suspected changes 
ignited within the descending part of the duodenum 
due to presence of a small amount of fluid in the area. 
Initially it was suspected as the cause of symptoms of 
the gastric anastomotic leak, but the radiation leak test 
with an aqueous solution uropolin ruled out this cause. 
A panendoscopy did not confirm a peptic ulcer disease. 
A computed tomography of the abdomen showed some 
inflammatory infiltration within the network covering the 
duodenum and blood supply disorders coexisting within 
the inflammatory hepatic hilar region. There was also 
a small amount of fluid in the pleural cavities and inflam-
matory changes in the lower lobe of the left lung. No 
pathogens grew in the blood culture. The ultrasound, sup-
plemented by Doppler, indicated that there were no other 
pathological changes in the abdomen other than those 
previously detected. In addition to a standard procedure 
which includes prophylaxis with low molecular weight 
heparin, pain killers, proton pump inhibitors, antibiotic 
(amoxicillin + clavulanate), metronidazol, fluid therapy 
2500 ml/day and naso-gastric tube initially used (which 
was removed), an extended antibiotic therapy (piper-
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cyline + tazobactam) and a nutritional regime – diet “0” 
(+ parenteral nutrition) were introduced. A gradual de-
crease in hemoglobin concentration to 7.9 g/dL and a drop 
in the hematocrit to 24.9% were observed on the 9th day 
of hospitalization — the patient received a transfusion of 
two units of PRBC, and after a week, due to the growing 
anemia, another three units of PRBC were transfused. 
During the fourth week of the hospitalization, the high 
CRP values 295 mg/L, a high level of bilirubin (3 mg/dL), 
an increase in AST to 121 U/L and an ever-growing value 
of GGTP (401 U/L) with a temporary increase in the body 
temperature to 39 degrees were observed. An angio-CT 
of the abdomen was performed. The study confirmed 
presence of inflammatory lesions in the liver, portal vein 
thrombosis and presence of the thrombus in the splenic 
vein and superior mesenteric vein initial section. The 
diagnosis was confirmed by a Doppler ultrasound study. 
Following the diagnosis, a 24-hour infusion of unfraction-
ated heparin was administered (30,000 units per day) 
using an infusion pump, under the control of APTT. On 
the seventh day of heparinizing, a Doppler examination 
found a partial regression of changes in the portal vein. 
On the 10th day of the treatment an infusion of unfrac-
tionated heparin through an infusion pump was con-
ducted. Again, low molecular weight heparin was used 
at a therapeutic dose. Then, after a further regression of 
thrombotic lesions, in the eight week of hospitalization, 
the patient was given an oral anticoagulant therapy, under 
the control of INR in the therapeutic range. The patient 
was discharged home with recommendations of a further 
oral anticoagulant therapy and an ambulatory control of 
the metabolic surgery. During follow-up outpatient visits, 
we found a gradual reduction of thrombotic changes in 
the portal vein system with a full withdrawal in the 41st 
week since their occurrence.
Discussion
According to the WHO in 2008, more than 1.4 billion 
adults were overweight and more than half a billion were 
obese. At least 2.8 million people each year die as a result 
of being overweight or obese. The prevalence of obesity 
has nearly doubled between 1980 and 2008 [8]. Accord-
ing to data 2011 from the Central Statistical Office, 18% 
of adults in Poland are obese, and 52% are overweight. 
Therefore it is understandable that we see a  growing 
interest in bariatric surgery. In recent years there have 
been numerous clinical studies documenting the high 
efficacy of such surgeries, especially when compared with 
conservative methods such as drug therapy or lifestyle 
changes. The success of bariatric surgery is defined as 
a  lasting weight loss and a normalization of metabolic 
parameters. Despite undoubtedly numerous advantages 
of bariatric surgery, the classification of patients for such 
surgery should be performed in a thoughtful and careful 
manner. Although bariatric surgery is thought to have 
a relatively low rate of serious complications — 2.5% — 
the nature of the procedure carries high risk for surgical 
patients [9]. A sleeve gastrectomy is currently the most 
frequently performed bariatric procedure in Poland [10]. 
It owes its popularity to relatively fast effects of weight 
loss and low metabolic disturbance. The complications 
associated with this technique include mainly leakage 
of the anastomosis, bleeding, stricture of the stomach, 
a gastroesophageal reflux disease, intra-abdominal ab-
scesses, and wound infections. However, there can also 
be other complications such as pulmonary embolism, 
peritonitis, pneumonia and a respiratory failure. The over-
all risk of death associated with this procedure amounts 
to 0.19% [11].
Portal vein thrombosis, a  complication of a  cuffed 
laparoscopic sleeve gastrectomy, is very rare and the 
symptoms are atypical. Their intensity directly correlates 
with the extent of thrombosis. In the case of portal vein 
thrombosis the symptoms most frequently reported by 
patients were non-specific abdominal pain (90%), vom-
iting (77%), nausea (54%), diarrhea (36%) and less com-
monly abdominal distension, fever and bleeding from 
esophageal varices. Undetected portal vein thrombosis 
may extend to the adjacent vessel. When the flow impair-
ment also applies to the inferior mesenteric, a severe colic 
pain and bloody stools may occur, consequently, this 
condition can lead to bowel ischemia and the formation of 
a portal hypertension, a late complication. Most patients 
experience symptoms for approximately two days before 
reporting them to the doctor [3]. Typical laboratory tests 
often are not helpful in the diagnosis, especially in the 
early stages of the disease.
Concerning our case, the results of the previous re-
search were published in JAMA Surgery, an American 
medical journal, and included an impressive (in terms of 
scale) retrospective study [4], which rated incidents of 
portal vein thrombosis among patients undergoing lapa-
roscopic bariatric surgery. Among 5,706 patients from six 
academic centers, 17 (or 0.3%), 16 after the sleeve and 
one after the band, had portal vein thrombosis. Although 
thrombosis as a complication of bariatric surgery may 
seem extremely rare, we have noticed more and more 
references to such complications in foreign medical liter-
ature, which seems to be associated with the increase in 
bariatric procedures. The laparoscopic treatment of obe-
sity, a sleeve gastrectomy in particular, is still a relatively 
new method. Out of the diagnostic arsenal at our disposal 
(ultrasound, Doppler, CT, MRI), the angio-CT seems most 
effective, though the diagnosis should begin with a Dop-
pler ultrasound, which has an extremely high negative 
predictive value, close to 98% [2]. The treatment aims to 
restore patency of the portal vein and prevent the spread 
of the splenic vein thrombosis and superior mesenteric. If 
applicable, according to a standard regimen unfractionat-
ed heparin or heparin at therapeutic doses followed by an 
oral anticoagulant should be administered, preferably for 
three-to-six months depending on risk factors. In the vast 
majority of cases, this treatment is sufficient. In a small 
number of cases, an endovascular intervention may be 
needed. In this case, our treatment did not deviate from 
the standards. Before readmitting the patient to hospital, 
we can find a number of risk factors leading to thrombosis 
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besides a history of a laparoscopic sleeve gastrectomy. 
The patients who underwent this type of surgery typi-
cally smoked approximately a pack of cigarettes a day 
and applied oral hormonal contraception. Probably the 
decisive factor for thrombosis within the portal system 
was ongoing inflammation of the duodenum network 
bags and gallbladder, as well as blood supply disorders 
coexisting within the inflammatory hepatic hilar region.
Conclusion
Portal vein thrombosis is a rare, but potentially, dan-
gerous complication that always needs to be considered 
if patients report non-specific symptoms from the abdom-
inal cavity a few days to a few weeks after a laparoscopic 
bariatric procedure. The differential diagnosis in these 
patients should include Doppler examinations, and in 
unclear cases, an angio-CT scan should be performed.
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